Insufficient scRNA-seq data for expression of YBX2 at single-cell level.
Insufficient scRNA-seq data for expression of YBX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 97% | 898.38 | 936 / 966 | 87% | 11.80 | 456 / 527 |
breast | 99% | 491.32 | 455 / 459 | 77% | 7.25 | 857 / 1118 |
uterus | 91% | 189.12 | 155 / 170 | 76% | 11.69 | 348 / 459 |
stomach | 85% | 108.72 | 304 / 359 | 81% | 10.66 | 233 / 286 |
esophagus | 98% | 336.54 | 1421 / 1445 | 63% | 6.83 | 115 / 183 |
kidney | 97% | 209.08 | 86 / 89 | 38% | 2.32 | 340 / 901 |
thymus | 100% | 345.52 | 651 / 653 | 31% | 1.21 | 187 / 605 |
ovary | 28% | 26.81 | 50 / 180 | 85% | 8.80 | 365 / 430 |
liver | 80% | 152.69 | 181 / 226 | 33% | 3.06 | 132 / 406 |
adipose | 98% | 346.85 | 1179 / 1204 | 0% | 0 | 0 / 0 |
muscle | 95% | 133.99 | 764 / 803 | 0% | 0 | 0 / 0 |
bladder | 52% | 81.90 | 11 / 21 | 38% | 4.13 | 193 / 504 |
prostate | 84% | 186.72 | 205 / 245 | 5% | 0.16 | 26 / 502 |
tonsil | 0% | 0 | 0 / 0 | 87% | 14.77 | 39 / 45 |
skin | 70% | 207.15 | 1273 / 1809 | 14% | 0.65 | 68 / 472 |
heart | 80% | 80.76 | 685 / 861 | 0% | 0 | 0 / 0 |
lung | 7% | 8.31 | 40 / 578 | 47% | 4.08 | 545 / 1155 |
brain | 39% | 71.65 | 1019 / 2642 | 4% | 0.20 | 31 / 705 |
pancreas | 11% | 7.80 | 35 / 328 | 11% | 0.83 | 20 / 178 |
blood vessel | 17% | 20.81 | 221 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 4% | 4.80 | 10 / 258 | 3% | 0.19 | 8 / 230 |
eye | 0% | 0 | 0 / 0 | 5% | 0.14 | 4 / 80 |
spleen | 5% | 3.13 | 11 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.70 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0048599 | Biological process | oocyte development |
GO_0010468 | Biological process | regulation of gene expression |
GO_0007283 | Biological process | spermatogenesis |
GO_0009386 | Biological process | translational attenuation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | YBX2 |
Protein name | Y-box-binding protein 2 (Contrin) (DNA-binding protein C) (Dbpc) (Germ cell-specific Y-box-binding protein) (MSY2 homolog) Alternative protein YBX2 Y-box binding protein 2 |
Synonyms | MSY2 CSDA3 |
Description | FUNCTION: Major constituent of messenger ribonucleoprotein particles (mRNPs). Involved in the regulation of the stability and/or translation of germ cell mRNAs. Binds to Y-box consensus promoter element. Binds to full-length mRNA with high affinity in a sequence-independent manner. Binds to short RNA sequences containing the consensus site 5'-UCCAUCA-3' with low affinity and limited sequence specificity. Its binding with maternal mRNAs is necessary for its cytoplasmic retention. May mark specific mRNAs (those transcribed from Y-box promoters) in the nucleus for cytoplasmic storage, thereby linking transcription and mRNA storage/translational delay (By similarity). . |
Accessions | ENST00000007699.10 L8EAU5 ENST00000571464.1 I3L2D6 Q9Y2T7 ENST00000672150.1 |